Michael Parini moves from Pfizer to Vertex

Will be the USbiotech's chief legal officer

Vertex
Pharmaceuticals has appointed Michael Parini as executive vice president and
chief legal officer.

He joins Boston-based biotech company from Pfizer, where
he served for more than a decade, in various leadership roles within the
company's global legal team.

Most recently, he served as senior vice president and
associate general counsel and was responsible for the strategic management of
Pfizer's global litigation activities, including its civil, intellectual
property, government and employment litigation.

He said: "I've watched Vertex's evolution over
recent years and am thrilled to join this team at such an exciting and pivotal
time in the company's history. I believe that Vertex is one of very few companies
that has the potential to make a fundamental change in the treatment of many
serious diseases.”

Parini will begin his role with Vertex on January 4,
2016, and will also serve as a member of its executive committee,
reporting directly to Jeffrey Leiden,

Vertex's chairman, president
and chief executive officer.
Leiden said: "Michael brings to Vertex
extensive global legal experience related to the development and
commercialisation of multiple medicines.

“I welcome Michael to the Vertex team and believe his
expertise will be invaluable as we bring our cystic fibrosis medicines to more
people worldwide and advance key research and development programmes across
many diseases.”

Prior to Pfizer,
Parini served as a health care attorney at Akin, Gump, Strauss, Hauer &
Feld, providing legal counsel on federal and state regulatory and policy
issues.